
Drug Target Models
GPCR Reporter Cells
Immunotherapy cells
Other Stable Cells
Assay Kits & Reagents
Services
Resources
Company
We Are Pleased to Announce: Global Commercial Licensing Rights for Jurkat E6.1, CHO-K1, HEK293, THP-1 and RAJI Cell Lines Officially Secured.
Explore

Figure 1. HTRF cAMP Assay with GRM4 CHO-K1(C12)
L-Glutamate induced a dose-dependent response with EC50 = 5.03 μM. The data confirms functional GRM4 receptor activity, suitable for pharmacological profiling and compound screening.

Figure 2. Dose-response of Etelcalcetide hydrochloride in CaSR NFAT-Luc HEK293 (C15) cells
Red curve: Etelcalcetide hydrochloride alone, EC50 = 14.4 μM. Yellow curve: Etelcalcetide hydrochloride with 1 mM CaCl₂, EC50 = 1.52 μM. The data demonstrates allosteric potentiation of CaSR, confirming functional receptor activity for pharmacological study and compound screening.